An increase in the number of older people experiencing disability and dependence is a critical aspect of the demographic change that will emerge within Europe due to the rise in life expectancy. In this scenario, prevention of these conditions is crucial for the well-being of older citizens and for the sustainability of our healthcare systems. Thus, the diagnosis and management of conditions like frailty, which identifies the people at the highest risk for developing those adverse outcomes, is of critical relevance. Currently, assessment of frailty relies primarily on measuring functional parameters, which have limited clinical utility. In this viewpoint article, we describe the FRAILOMIC Initiative, an international, large-scale, multi-endpoint, community- and clinic-based research study funded by the European Commission. The aim of the study is to develop validated measures, comprising both classic and ‘omics-based' laboratory biomarkers, which can predict the risk of frailty, improve the accuracy of its diagnosis in clinical practice and provide a prognostic forecast on the evolution from frailty to disability. The initiative includes eight established cohorts of older adults, encompassing >75,000 subjects, most of whom (∼70%) are aged >65 years. Data on function, nutritional status and exercise habits have been collected, and cardiovascular health has been evaluated at baseline. Subjects will be stratified as ‘non-frail' or ‘frail' using Fried's definition, all adverse outcomes of interest will be recorded and differentially expressed biomarkers associated with the risk of frailty will be identified. Genomic, proteomic and transcriptomic investigations will be carried out using array-based systems. As circulating microRNAs in plasma have been identified in the context of senescence, ageing and age-associated diseases, a miRNome-wide analysis will also be undertaken to identify a miRNA-based signature of frailty. Blood concentrations of secreted proteins known to be upregulated significantly in senescent endothelial cells and other hypothesis-driven biomarkers will be measured using ELISAs. The FRAILOMIC Initiative aims to issue a series of interim scientific reports as key results emerge. Ultimately, it is hoped that this study will contribute to the development of new clinical tools, which may help individuals to enjoy an old age that is healthier and free from disability.

1.
European Commission: The 2012 Ageing Report: Underlying Assumptions and Projection Methodologies. Brussels, European Union, 2011.
2.
Murray CJL, Lopez AD: Measuring the global burden of disease. N Engl J Med 2013;369:448-457.
3.
Christensen K, Thinggaard M, Oksuzyan A, Steenstrup T, Andersen-Ranberg K, Jeune B, et al: Physical and cognitive functioning of people older than 90 years: a comparison of two Danish cohorts born 10 years apart. Lancet 2013;382:1507-1513.
4.
Gill TM, Gahbauer EA, Han L, Allore HG: The relationship between intervening hospitalizations and transitions between frailty states. J Gerontol A Biol Sci Med Sci 2011;66A:1238-1243.
5.
Walston J, Fried LP: Frailty and the older man. Med Clin North Am 1999;83:1173-1194.
6.
WHO: International Classification of Impairments, Disabilities and Handicaps. A Manual of Classification Relating to the Consequences of Disease. Geneva, WHO, 1980.
7.
Beloosesky Y, Hershkovitz A, Solovey B, Salai M, Weiss A: Hip fracture post-operation dysnatremia and Na+-courses in different cognitive and functional patient groups. Arch Gerontol Geriatr 2011;53:179-182.
8.
Fried LP, Tangen CM, Walston J, Newman AB, Hirsch C, Gottdiener J, Seeman T, Tracy R, Kop WJ, Burke G, McBurnie MA; Cardiovascular Health Study Collaborative Research Group: Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci 2001;56:M146-M156.
9.
Pahor M, Guralnik JM, Ambrosius WT, et al: Effect of structured physical activity on prevention of major mobility disability in older adults: the LIFE study randomized clinical trial. JAMA 2014;311:2387-2396.
10.
Rodriguez-Mañas L, Fried LP: Frailty in the clinical scenario. Lancet 2015;385:e7-e9.
11.
Malani PN: Functional status assessment in the preoperative evaluation of older adults. JAMA 2009;302:1582-1583.
12.
Afilalo J, Karunananthan S, Eisenberg MJ, Alexander KP, Bergman H: Role of frailty in patients with cardiovascular disease. Am J Cardiol 2009;103:1616-1621.
13.
Ferrucci L, Guralnik JM, Cavazzini C, Bandinelli S, Lauretani F, Bartali P, Repetto L, Longo DL: The frailty syndrome: a critical issue in geriatric oncology. Crit Rev Oncol Hematol 2003;46:127-137.
14.
Rodriguez-Mañas L, Féart C, Mann G, Viña J, Chatterji S, Chodzko-Zajko W, et al: Searching for an operation al definition of frailty: a Delphi method based consensus statement: the frailty operative definition-consensus conference project. J Gerontol A Biol Sci Med Sci 2013;68:62-67.
15.
Sourial N, Bergman H, Karunananthan S, Wolfson C, Payette H, Gutierrez-Robledo LM, Bèland F, Fletcher JD, Guralnik J: Implementing frailty into clinical practice: a cautionary tale. J Gerontol A Biol Sci Med Sci 2013;68:1505-1511.
16.
Garcia-Garcia FJ, Gutierrez Avila G, Alfaro Acha A, et al: The prevalence of frailty syndrome in an older population from Spain. The Toledo Study for Healthy Aging. J Nutr Health Aging 2011;15:852-856.
17.
Fried LP, Guralnik JM: Disability in older adults: evidence regarding significance, etiology, and risk. J Am Geriatr Soc 1997;45:92-100.
18.
Rockwood K, Howlett SE, MacKnight C, Beattie BL, Bergman H, Hébert R, Hogan DB, Wolfson C, McDowell I: Prevalence, attributes, and outcomes of fitness and frailty in community-dwelling older adults: report from the Canadian Study of Health and Aging. J Gerontol A Biol Sci Med Sci 2004;59:1310-1317.
19.
Lunney JR, Lynn J, Foley DJ, Lipson S, Guralnik JM: Patterns in functional decline at the end of life. JAMA 2003;289:2387-2392.
20.
Clegg A, Young J, Iliffe S, Rikkert MO, Rockwood K: Frailty in elderly people. Lancet 2013;381:752-762.
21.
Syddall H, Cooper C, Martin F, Briggs R, Aihie Sayer A: Is grip strength a useful single marker of frailty? Age Ageing 2003;32:650-656.
22.
Bartali B, Frongillo EA, Bandinelli S, Lauretani F, Semba RD, Fried LP, Ferrucci L: Low nutrient intake is an essential component of frailty in older persons. J Gerontol A Biol Sci Med Sci 2006;61:589-593.
23.
Michelon E, Blaum C, Semba RD, Xue QL, Ricks MO, Fried LP: Vitamin and carotenoid status in older women: associations with the frailty syndrome. J Gerontol A Biol Sci Med Sci 2006;61:600-607.
24.
Bandinelli S, Lauretani F, Boscherini V, Gandi F, Pozzi M, Corsi AM, Bartali B, Lova RM, Guralnik JM, Ferruci L: A randomized, controlled trial of disability prevention in frail older patients screened in primary care: the FRASI Study. Design and baseline evaluation. Aging Clin Exp Res 2006;18:359-366.
25.
Fried LP, Walston JD: Frailty; in Halter JB, Ouslander JG, Tinetti ME, et al (eds): Hazzard's Geriatric Medicine and Gerontology, ed 6. New York, McGraw-Hill, 2009.
26.
Kelaiditi E, van Kan GA, Cesari M: Frailty: role of nutrition and exercise. Curr Opin Clin Nutr Metab Care 2014;17:32-39.
27.
Waters DL, Brooks WM, Qualls CR, Baumgartner RN: Skeletal muscle mitochondrial dysfunction and lean body mass in healthy exercising elderly. Mech Ageing Dev 2003;124:301-309.
28.
Carcaillon L, Blanco C, Alonso-Bouzón C, Alfaro-Acha A, García-García F-J, Rodriguez-Mañas L: Sex differences in the association between serum levels of testosterone and frailty in an elderly population: the Toledo Study for Healthy Aging. PLoS One 2012;7:e32401.
29.
Carcaillon L, García-García FJ, Tresguerres JA, Gutiérrez Avila G, Kireev R, Rodríguez-Mañas L: Higher levels of endogenous estradiol are associated with frailty in postmenopausal women from the Toledo Study for Healthy Aging. J Clin Endocrinol Metab 2012;97:2898-2906.
30.
Vanitallie TB: Frailty in the elderly: contributions of sarcopenia and visceral protein depletion. Metabolism 2003;52(suppl 2):22-26.
31.
Leng S, Chaves P, Koenig K, Walston J: Serum interleukin-6 and hemoglobin as physiological correlates in the geriatric syndrome of aging: a pilot study. J Am Geriatr Soc 2002;50:1268-1271.
32.
Walston J, McBurnie MA, Newman A, Tracy RP, Kop WJ, Hirsch CH, Gottdiener J, Fried LP; Cardiovascular Health Study: Frailty and activation of the inflammation and coagulation systems with and without clinical comorbidities: results from the Cardiovascular Health Study. Arch Intern Med 2002;162:2333-2341.
33.
Inglés M, Gambini J, Carnicero JA, García-García FJ, Rodríguez-Mañas L, Olaso-González G, Dromant M, Borrás C, Viña J: Oxidative stress is related to frailty, not to age or sex, in a geriatric population: lipid and protein oxidation as biomarkers of frailty. J Am Geriatr Soc 2014;62:1324-1328.
34.
Buchman AS, Boyle PA, Wilson RS, Tang Y, Bennett DA: Frailty is associated with incident Alzheimer's disease and cognitive decline in the elderly. Psychosom Med 2007;69:483-489.
35.
Newman AB, Gottdiener JS, McBurnie MA, Hirsch CH, Kop WJ, Tracy R, Walston JD, Fried LP; Cardiovascular Health Study Research Group: Associations of subclinical cardiovascular disease with frailty. J Gerontol A Biol Sci Med Sci 2001;56:M158-M166.
36.
Hubbard RE, Andrew MK, Fallah N, Rockwood K: Comparison of the prognostic importance of diagnosed diabetes, co-morbidity and frailty in older people. Diabet Med 2010;27:603-606.
37.
Ekerstad N, Swahn E, Janzon M, Alfredsson J, Löfmark R, Lindenberger M, Carlsson P: Frailty is independently associated with short-term outcomes for elderly patients with non-ST-segment elevation myocardial infarction. Circulation 2011;124:2397-2404.
38.
Alonso-Bouzón C, Carcaillon L, García-García FJ, Amor-Andrés MS, El Assar M, Rodríguez-Mañas L: Association between endothelial dysfunction and frailty: the Toledo Study for Healthy Aging. Age (Dordr) 2014;36:495-505.
39.
Baker DJ, Wijshake T, Tchkonia T, LeBrasseur NK, Childs BG, van de Sluis B, Kirkland JL, van Deursen JM: Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders. Nature 2011;479:232-236.
40.
Erusalimsky JD: Vascular endothelial senescence: from mechanisms to pathophysiology. J Appl Physiol 2009;106:326-332.
41.
Coppé JP, Desprez PY, Krtolica A, Campisi J: The senescence-associated secretory phenotype: the dark side of tumor suppression. Annu Rev Pathol 2010;5:99-118.
42.
Laschober GT, Ruli D, Hofer E, et al: Identification of evolutionarily conserved genetic regulators of cellular aging. Aging Cell 2010;9:1084-1097.
43.
Nilsson R, Björkegren J, Tegnér J: On reliable discovery of molecular signatures. BMC Bioinformatics 2009;10:38.
44.
Vera E, Blasco MA: Beyond average: potential for measurement of short telomeres. Aging 2012;4:379-392.
45.
Weilner S, Schraml E, Redl H, Grillari-Voglauer R, Grillari J: Secretion of microvesicular miRNAs in cellular and organismal aging. Exp Gerontol 2013;48:626-633.
46.
European Union: European Year of Active Ageing and Solidarity between Generations 2012. http://europa.eu/ey2012/.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.